Recent patenting activities in the discovery and development of vasopressin V₂ receptor agonists

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.6, 2012-06, pp. : 579-586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent discovery and development of non-peptide vasopressin V2 receptor agonists

By Kondo Kazumi

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 8, 2002-08 ,pp. : 1249-1258

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in the development of melanocortin-4 receptor agonists

By Speake Jason D Bishop Michael J

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1631-1638

Informa Healthcare

Access to resources Recommend Favorite

Recent advances towards the discovery of ORL-1 receptor agonists and antagonists

By Bignan Gilles C Connolly Peter J Middleton Steven A

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 357-388

Informa Healthcare

Access to resources Recommend Favorite

Stability of the vasopressin V 2 receptor-adenylyl cyclase system in rat kidney

By Shen T. Laycock J. Suzuki Y. Defer N. Hanoune J.

European Journal of Pharmacology, Vol. 341, Iss. 1, 1998-01 ,pp. : 87-94

Elsevier

Access to resources Recommend Favorite

Recent discovery and development of endothelin receptor antagonists

By Wu C.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1653-1668

Informa Healthcare

Access to resources Recommend Favorite